Pasithea Therapeutics Ratios (2021-2024) | KTTA

Ratios Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Profitability
Gross Margin 5.28%-11.19%60.45%100.54%
EBT Margin -11,526.14%-16,124.43%-1,917.15%-1,683.92%5,475.32%-1,034.50%
EBIT Margin -17,605.34%-19,229.50%-1,763.76%-1,679.52%5,386.03%-1,100.81%
EBITDA Margin -11,559.18%-19,935.05%-2,135.62%-2,065.45%5,935.29%-1,082.08%
Operating Margin -17,605.34%-19,229.50%-1,763.76%-1,679.52%5,386.03%-1,100.81%
Net Margin -2,384.38%-3,449.93%-180.73%-442.14%455.80%-47.48%
FCF Margin -15,771.77%-14,302.08%-2,116.61%-1,361.84%5,459.15%-886.34%
Efficiency
Assets Average 37.18M52.20M52.05M51.32M47.39M43.61M40.10M34.40M28.39M24.26M20.04M18.15M
Equity Average 33.95M50.70M50.73M49.13M44.64M40.82M37.36M31.98M25.89M21.64M18.03M16.99M
Invested Capital 16.48M51.42M49.98M51.47M46.79M42.51M39.15M35.59M28.37M23.40M19.88M16.18M17.81M
Asset Utilization Ratio 0.000.000.000.010.010.020.020.010.01
Leverage & Solvency
Interest Coverage Ratio -502.9032.67
Debt to Equity 0.000.000.00
Debt Ratio 0.000.000.00
Equity Ratio 0.780.960.980.970.940.940.930.930.930.900.890.920.96
Times Interest Earned -502.9032.67
Valuation
Enterprise Value -20.57M-52.97M-50.32M-47.94M-42.40M-33.09M-29.91M-26.77M-19.70M-16.33M-12.01M-8.00M-9.36M
Return Ratios
Return on Sales -23.84%-34.50%-1.81%-4.42%4.56%-0.47%-2.84%-1.58%-11.62%
Return on Capital Employed -0.12%-0.12%-0.16%-0.22%-0.28%-0.33%-0.39%-0.46%-0.62%-0.77%-0.91%-0.92%
Return on Assets -0.06%-0.04%-0.03%-0.01%-0.05%-0.05%-0.05%-0.04%-0.02%-0.17%-0.39%-0.59%
Return on Equity -0.06%-0.04%-0.03%-0.01%-0.05%-0.05%-0.05%-0.05%-0.02%-0.19%-0.43%-0.63%